Publications

Search our bibliography using the filters on the right-hand side.

Displaying 201 through 250 of 341 publications.

Balp M, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Hollis K, Khalil S, Knulst A, Lacour J, Lynde C, Marsland A, Maurer M, McBride D, Nakonechna A, Ortiz de Frutoz FJ, Oude Elberink J, Proctor C, Sussman G, Weller K, Grattan C. Comparison of direct healthcare costs associated with chronic spontaneous/idiopathic urticaria in 7 countries - results from the ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A565.

Wheeler A, Sacco P, Rakhit A, Cabo R. Identifying the unmet medical need of Angelman Syndrome: results of a targeted literature review. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A579.

Hollis K, Abuzakouk M, Balp M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Khalil S, Knulst AC, Lacour J, Lynde C, Maurer M, McBride D, Nakonechna A, Ortiz De Frutos J, Oude Elberink J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Marsland A. Assessing health-utility values for chronic spontaneous/idiopathic urticaria in real-world using the EQ-5D: results from ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A570-1.

Mease P, Schwab PE, Dinh H, Sheer R, Cappelleri J, Bananis E, Harnett J, Hsu MA. Treatment patterns, health care resource utilization, and costs associated with psoriatic arthritis among Humana commercial and Medicare member populations. Poster presented at the 2016 Academy of Managed Care Pharmacy's 28th Annual Meeting & Expo; October 3, 2016. National Harbor, MD.

Swanger C, Tobbe C, Schwab PE, Lane D, Hurwitch A. Opioid utilization patterns in a humana commercial and medicare population. Poster presented at the 2016 Academy of Managed Care Pharmacy's 28th Annual Meeting & Expo; October 3, 2016. National Harbor, MD. [abstract] J Manag Care Pharm. 2016 Oct; 22(10-a).

Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264

Bailey RA, Schwab P, Xu Y, Pasquale M, Renda A. Glycemic control outcomes after Canagliflozin initiation: observations in a Medicare and commercial managed care population in clinical practice. Clin Ther. 2016 Sep;38(9):2046-2057. doi: 10.1016/j.clinthera.2016.07.009

Marion S, Tzivelekis S, Darden C, Price MA, Sherif B, Garcia J, Kaye JA, Chandler D. "Same-day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Support Care Cancer. 2016 Sep;24(9):3889-96. doi: 10.1007/s00520-016-3193-3

Lewis JH, Whelihan K, Navarro I, Boyle KR, SDH Card Study Implementation Team. Community health center provider ability to identify, treat and account for the social determinants of health: a card study. BMC Fam Pract. 2016 Aug 27;17(1):121. doi: 10.1186/s12875-016-0526-8

Davis K, Asiimwe A, Zografos L, McSorley D. Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 μg. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):309-10.

Zografos LJ, Andrews E, Whalley D, Petraro P, Vassilev Z. Use of cognitive testing to optimize questionnaire wording and mode of administration in the evaluation of risk minimization activities. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):319-20.

Zografos LJ, Suzart K, Horvat-Broecker A, Soriano-Gabarro M, Wolin DL, Calingaer B, Davenport EK, Hollis KA, Andrews E. Evaluating physician knowledge of risks and safe use of Xarelto (rivaroxaban). Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 27, 2016. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2016 Aug; 25(Suppl 3):288-9.

Ueng W, McGuinness J, Infante K, Trivedi MS, Yi HS, David R, Vanegas A, Vargas J, Sandoval R, Kukafka R, Crew KD. Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women. Poster presented at the 107th Annual Meeting of the American Association for Cancer Research; April 2016. New Orleans, LA. [abstract] Cancer Res. 2016 Jul; 76(14_Suppl). doi: 10.1158/1538-7445.AM2016-1790

White MV, Silvia S, Hollis K, Goss D, Odom D, Bartsch J, Hogue SL. EPIPEN4SCHOOLS® survey combined analysis: prevalence and triggers of anaphylactic events. Poster presented at the NASN 2016 48th Annual Conference; June 30, 2016. Indianapolis, IN. Previously presented at the 2016 AAAAI Annual Meeting.

White MV, Goss D, Hollis K, Millar K, Silvia S, Siegel PH, Bennett ME, Wooddell MJ, Hogue SL. Anaphylaxis triggers and treatments by grade level and staff training: findings from the EPIPEN4SCHOOLS pilot survey. Pediatr Allergy Immunol Pulmonol. 2016 Jun 16;29(2):80-5. doi: 10.1089/ped.2015.0614

Yu S, Schwab P, Bian B, Radican L, Tunceli K. Use of add-on treatment to Metformin monotherapy for patients with type 2 Diabetes and suboptimal glycemic control: a U.S. database study. J Manag Care Spec Pharm. 2016 Mar;22(3):272-80. doi: 10.18553/jmcp.2016.22.3.272

Schwab P, Saundankar V, Bouchard J, Wintfeld N, Suehs B, Moretz C, Allen E, DeLuzio A. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Res Care. 2016 Feb 18;4(1):e000099. doi: 10.1136/bmjdrc-2015-000099

White MV, Silvia S, Hollis K, Wooddell M, Goss D, Odom D, Cooney D, Bartsch J, Hogue S. EPIPEN4SCHOOLS® survey combined analysis: prevalence and triggers of anaphylactic events. Poster presented at the 2016 AAAAI Annual Meeting; March 4, 2016. Los Angeles, CA. [abstract] J Allergy Clin Immunol. 2016; 137:AB52.

Darden CM, Price MA, Kaye JA, Sherif BN, Marion S, Tzivelekis S, Garcia J, Chandler D. Same-day administration of pegfilgrastim following myelosuppressive chemotherapy: practices and rationale. Blood. 2015 Dec 3;126(23):5585. doi: 10.1182/blood.V126.23.5585.5585

Schwab PE, MacLean E, Chioda M, Moll K, Pasquale M, Mardekian J, Futch T. NSCLC observations combining medical charts and administrative claims data. Poster presented at the 2015 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5, 2015. Boston, MA. [abstract] Mol Tar Can Ther. 2015 Dec 1; 14(12 S2).

Balp MM, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Maurer M, Koenders J, Knulst AC, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Tian H, Elberink JN. Work productivity and activity impairment among chronic spontaneous/idiopathic urticaria patients: results from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Tian H, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Koenders J, Knulst AC, Elberink JN, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Balp MM, Maurer M. Healthcare resource utilisation among chronic spontaneous/idiopathic urticaria patients- findings from the first international burden of illness study (ASSURE-CSU). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Silvia S, Hollis K, Wooddell MJ, Hogue S, White MV. The Epipen4schools® survey: prevalence and triggers of anaphylactic events in large US school districts. Presented at the 2015 ACAAI Conference; November 2015. San Antonio, TX.

White MV, Silvia S, Hollis KA, Wooddell M, Hogue SL. Characteristics and treatment of anaphylactic events in a US school setting: results from the EPIPEN4SCHOOLS® program survey. Poster presented at the American Academy of Pediatrics 2015; October 24, 2015. Washington, DC. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 CSACI Annual Scientific Meeting; October 24, 2015. Vancouver, Canada. Previously presented at the 2015 Eastern Allergy Conference.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Epipen4schools® program pilot survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 XXIV World Allergy Congress (WAC); October 16, 2015. Seoul, Korea.

Raspa M, Sacco PN, Edwards AM, Bishop E, Wylie AC, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 2nd International Conference on FMR1 Premutation: Basic Mechanisms and Clinical Involvement; October 2015. Barcelona, Spain. Previously presented at the 48th Annual Gatlinburg Conference.

Weller K, Grattan C, Abuzakouk M, Berard F, Sussman G, Lynde C, Canonica GW, Knulst A, Ortiz De Frutos J, Nakonechna A, Gimenez-Arnau A, Oude Elberink JNG, Balp MM, Khalil S, Tian H, Hollis K, Sweeney C, Radder C, McBride D, Maurer M. Patient profile from the first international burden of illness study in inadequately controlled chronic spontaneous urticaria: ASSURE-CSU. Poster presented at the 24th European Academy of Dermatology and Venereology (EADV) Congress; October 2015. Copenhagen, Denmark.

Sheer R, Schwab PE, Noyes Essex M, Cappelleri JC, Reiners A, Bobula J, Pasquale M. Management due to sprains, strains and contusions in the Medicare population. Poster presented at the 2015 PAIN Week; September 8, 2015. Las Vegas, NV.

Sheer R, Schwab P, Essex MN, Cappelleri J, Reiners A, Bobula J, Pasquale M. Acute pain management due to sprains, strains and contusions in the medicare population. Poster presented at the PAINWeek 2015; 2015. Las Vegas, NV. [abstract] Postgrad Med. 2015 Sep 4; 127(S1):S86. doi: https://doi.org/10.1080/00325481.2015.1086533

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. Differences in anaphylaxis-related risks by school grade level: findings from the EpiPen4Schools® survey. Poster presented at the 2015 ASCIA Conference; September 2015. Adelaide, Australia. [abstract] Intern Med J. 2015 Sep 3; 45(Suppl 4):3. doi: 10.1111/imj.12869

Vekeman F, Gauthier-Loiselle M, Faust E, Lefebvre P, Lahoz R, Duh MS, Sacco P. Patient and caregiver burden associated with fragile x syndrome in the United States. Am J Intellect Dev Disabil. 2015 Sep;120(5):444-59. doi: 10.1352/1944-7558-120.5.444

Sussman G, Lynde C, Zanganeh S, Lacuesta G, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Sweeney CT, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: an analysis of the diagnosis and treatment of patients with antihistamine-refractory CSU. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada. [abstract] Clin Transl Allergy. 2015 Aug 17; 5(29):1-7. doi: 10.1186/s13601-015-0072-9

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz De Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM. ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin Transl Allergy. 2015 Aug 17;17(5):29.

White MV, Goss D, Silvia S, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics of anaphylaxis and common triggers. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Silvia S, Goss D, Wooddell M, Hogue S, White MV. Epinephrine administration for cases of anaphylaxis in a US school setting: results from the EpiPen4Schools® survey. Poster presented at the 2015 FAAIS Annual Meeting; July 17, 2015. Orlando, FL. Previously presented at the 2015 AAAAI Annual Meeting.

Sussman G, Lynde C, Kanani A, Hebert J, Chiva-Razavi S, Chambenoit O, Khalil S, Hollis KA, McBride DW, Westlund RE, Tian H, Balp MM. ASSURE-CSU preliminary Canadian results: redefining our understanding of the clinical characteristics of patients with CSU/CIU refractory to H1- antihistamines. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Grattan C, Lynde C, Abuzakouk M, Nakonechna A, Chiva-Razavi S, Halliday A, Chambenoit O, Hollis KA, McBride DW, Radder CN, Tian H, Balp MM. ASSURE-CSU preliminary UK and Canadian results: a characterisation of angioedema in patients with refractory CIU/CSU from the UK and Canada. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Sussman G, Nakonechna A, Lynde C, Grattan C, Halliday A, Chiva-Razavi S, Hollis KA, Balp MM. Impact of chronic idiopathic/ spontaneous urticaria on health related quality of life: aSSURE-CSU study results from Canada and the UK. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

Grattan C, Balp MM, Halliday A, Abouzakouk M, Hollis KA, McBride DW, Westlund RE, Wolin DL, Tian H, Alexopoulos ST, Nakonechna A. ASSURE-CSU preliminary UK results: assessing the impact of CSU on absence from work and work productivity. Poster presented at the 23rd World Congress of Dermatology; June 9, 2015. Vancouver, Canada.

White MV, Silvia S, Hollis K, Wooddell M, Hogue S. EpiPen4Schools® survey: characteristics and treatment of anaphylactic events in a US school setting. Poster presented at the 2015 Eastern Allergy Conference; May 28, 2015. Palm Beach, FL.

Sussman G, Waserman S, Keith P, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R. ASSURE-CSU Canadian results: assessing health utility in chronic spontaneous/idiopathic urticaria using the EQ-5D. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Sussman G, Lee J, Chiva-Razavi S, Chambenoit O, Hollis K, McBride D, Westlund R, Tian H, Balp MM. ASSURE-CSU Canadian results: assessing the impact of chronic spontaneous/idiopathic urticaria on work productivity and indirect costs. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Associations between comorbidities and hospitalizations among patients with chronic obstructive pulmonary disease (COPD). Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Schwab PE, Hopson S, Kaila S, Dhamane A, Moretz C, Burslem K, Jain G, Renda A. Association between nonadherence to chronic obstructive pulmonary disease (COPD) maintenance medications and medications for other chronic conditions. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Liu W, Schwab PE, Lane D. Analysis of oral anti-diabetes medication splitting patterns in Medicare Advantage Prescription Drug (MAPD) plans population. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Rosen J, Lane D, Schwab PE. Comparison of telephonic vs. face-to-face comprehensive medication reviews in COPD patients. Poster presented at the 2015 Academy of Managed Care Pharmacy's 27th Annual Meeting & Expo; April 7, 2015. San Diego, CA.

Raspa M, Sacco PN, Edwards AM, Bishop E, Bailey DB, Loefroth E. A cross-country comparison of caregiver burden in fragile X syndrome. Poster presented at the 48th Annual Gatlinburg Conference; April 2015. New Orleans, LA.

Sussman G, Lynde CW, Chiva-Razavi S, Chambenoit O, Hollis K, Westlund RE, Balp MM. Canadian sub-analysis of the ASSURE-CSU study: demographic characteristics and health related quality of life in patients with chronic idiopathic urticaria. Poster presented at the American Academy of Dermatology Annual Meeting; March 21, 2015. San Francisco, CA.

Sussman G, Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis K, McBride D, Balp MM, Berard F, Gimenez-Arnau AM, Frutos JO, Canonica GW, Knulst AC, Grattan C. Assessment of economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: study design of the first observational study, ASSURE-CSU. Poster presented at the American Academy of Dermatology Annual Meeting; March 20, 2015.